A Case Report on Recurrent Salivary Duct Carcinoma Treated with Casodex/Nolvadex and Traditional Korean Medicine |
Yang, Jung-min
(Jangdeuk Korean Medicine Hospital)
Jang, Kwon-jun (Jangdeuk Korean Medicine Hospital) Ko, Eun-bi (Jangdeuk Korean Medicine Hospital) Lee, Ji-yoon (Jangdeuk Korean Medicine Hospital) Yoon, Min-ji (Jangdeuk Korean Medicine Hospital) Jo, On-you (Jangdeuk Korean Medicine Hospital) Jeong, Seong-heon (Jangdeuk Korean Medicine Hospital) Moon, Hyang-ran (Jangdeuk Korean Medicine Hospital) Shin, Kwang-soon (Jangdeuk Korean Medicine Hospital) Hwang, Woo-seok (Jangdeuk Korean Medicine Hospital) |
1 | Di Villeneuve L, Souza IL, Tolentino FDS, Ferrarotto R, Schvartsman G. Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease. Front Oncol 2020 Oct 22;10:580141. DOI |
2 | 이인선, 장인규. An Experimental Study on Some Effects of SOEUMIN-HYANGSAYANGYUI-TANG. 경희한의대논문집 1989;12(1):153-70. |
3 | 건강보험심사평가원. 요법코드 2149. |
4 | Ellis GL, Auclair RL. Tumors of the Salivary Glands. Washington, DC. Armed forces institute of pathology; 2008. Atlast of Tumor Pathology; 4th series. |
5 | McHugh JB, Visscher DW, Barnes EL. Update on selected salivary gland neoplasms. Arch Pathol Lab Med 2009;133(11):1763-74. DOI |
6 | Annual report of cancer statistics in korea in 2018. National Cancer Center. Published 2021. Accessed January, 2021. |
7 | Sung IY, Kim UK, Kim JR, Chung IK. A Clincial Study on Malignant Salivary Gland Tumors. Journal of the Korean Association of Oral and Maxillofacial Surgeons 2000;26(4):427-34. |
8 | Lee JH, Shin DH. Pathological Classification and Diagnosis of the Salivary Gland Tumors. J Clin Otolaryngol Head Neck Surg 2020;31(1):18-28. DOI |
9 | 박종완, 최문영. Trastuzumab으로 치료한 HER2 양성 타액관암 1례. 2018년 제69차 대한내과학회 추계학술대회 2018:504. |
10 | Murase R, Sumida T, Ishikawa A, Murase R, McAllister SD, Hamakawa H, et al. Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer. Int J Otolaryngol 2011;2011:187623. doi: 10.1155/2011/187623. DOI |
11 | Yook TH, Song BY, Kim JW, Choi YM, Nam SS, Park YC, et al. Korean Medicine Clinical Practice Guideline for Facial Palsy 2019. |
12 | Yoo HS, Lee YY, Song KC, Choi BL, Seo SH, Cho JH, et al. The Effects of HangAmDan (HAD) on Anti-Metastasis and Preventing Relapses, Administered to 69 Cancer Patients. The Journal of Internal Korean Medicine 2002;23(2):165-73. |
13 | Han SS, Cho CK, Lee YW, Yoo HS. A Case Report on Extranodal Marginal Zone B Cell of Mucosa-associated Lymphoid Tissue (MALT) Type Lymphoma Treated with Hangam-dan. The Journal of Internal Korean Medicine 2008;29(3):810-8. |
14 | Yoon JH, Choi SH, Ahn KS. Anti-metastatic Effects of Shiquandabutang on Human Fibrosarcoma cells HT1080. J of Kor Oriental Oncology 1998;4(1):131-46. |
15 | Toriyama-Baba H, Ligo M, Asamoto M, Iwahori Y, Park CB, Han BS, et al. Organotropic Chemopreventive Effects of n- 3 Unsaturated Fatty Acids in a Rat Multi-organ Carcinogenesis Model. Jpn J Cancer Res 2001;92(11):1175-83. DOI |
16 | Watanabe H, Okada M, Kaji Y, Satouchi M, Sato Y, Yamabe Y, et al. [New Response Evaluation Criteria in Solid Tumours-Revised RECIST Guideline(version 1.1).]. Cancer & chemotherapy 2009;36(13):2495-501. |
17 | Sohaib A. RECIST rules. Cancer Imaging 2012;12(2):345-6. DOI |
18 | Kim JH, Shin HK. Analysis of Biological Experiment on Immunoactivity of Sipjeondabo-tang. Korean J Oriental Physiology & Pathology 2012;26(5):641-9. |
19 | Kim GH, Sung MW, Kim DY, Jung HS. Salivary Duct Carcinoma-2 Case Reports. Korean J Otolaryngol 2000;43:1129-33. |
20 | The Society of Internal Korean Medicine. Korean Medicine Clinical Practice Guideline for Functional Dyspepsia 2020. |
21 | Common Terminology Criteria for Adverse Events (CTCAE). National Cancer Institute. Availablefrom:URL:https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Published 2020. Accessed August 14, 2020. |
22 | National Comprehensive Cancer Network. Non-Small Cell Lung Cancer Metastatic. 2021. |
23 | Park MH, Ryu HS, Ro HY. Cho JS, Yoon JH, Jegal Yj, et al. The Clinical Significance of the Estrogen Receptor βExpression for Endocrine Therapy in Patients with ERα-negative and Progesterone Receptor-positive Breast Carcinoma. Breast Cancer 2009 Sep;12(3):156-62. DOI |
24 | Park SU, Kang SY, Kim TH, Kim CH. A Case Report of Salivary Duct Carcinoma. J Korean Soc Plast Reconstr Surg 2008;35(5):607-10. |
25 | Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma. Samsung Medical Center. URL: https://clinicaltrials.gov/ct2/show/NCT03614364 |
26 | Lee YJ, Koh YW, Yoon SO, Ryu HJ, Kim HR, Shin HA. Analysis of PD-L1 expression in salivary duct carcinoma with its efficacy as a tumor marker. Korean Journal of Head & Neck Oncology 2019;35(1):13-20. DOI |